Trial Profile
Offset of Ticagrelor's Effect on Endothelial Function as Assessed With Peripheral Arterial Tonometry (EndoPAT Assay)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 15 Sep 2015 New trial record
- 19 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.